|
INO80D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.250600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.545200E-01 |
| Normal-vs-Stage2 |
2.042600E-01 |
| Normal-vs-Stage3 |
6.144600E-01 |
| Normal-vs-Stage4 |
7.863200E-01 |
| Stage1-vs-Stage2 |
2.812600E-01 |
| Stage1-vs-Stage3 |
3.282000E-01 |
| Stage1-vs-Stage4 |
9.620000E-01 |
| Stage2-vs-Stage3 |
1.504820E-01 |
| Stage2-vs-Stage4 |
4.807600E-01 |
| Stage3-vs-Stage4 |
5.542800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.400000E-01 |
| Normal-vs-AfricanAmerican |
3.991400E-01 |
| Normal-vs-Asian |
6.253800E-01 |
| Caucasian-vs-AfricanAmerican |
8.564400E-01 |
| Caucasian-vs-Asian |
5.964800E-01 |
| AfricanAmerican-vs-Asian |
5.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.872600E-01 |
| Normal-vs-Female |
1.394190E-01 |
| Male-vs-Female |
3.287200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.720400E-01 |
| Normal-vs-Extreme_Weight |
5.647000E-01 |
| Normal-vs-Obese |
1.673570E-01 |
| Normal-vs-Extreme_Obese |
5.389000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.383200E-01 |
| Normal_Weight-vs-Obese |
3.240000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.200800E-01 |
| Extreme_Weight-vs-Obese |
6.354200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.851800E-01 |
| Obese-vs-Extreme_Obese |
9.339600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.165800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.561580E-02 |
| Normal-vs-Age(61-80Yrs) |
7.472400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.286600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.971200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.483800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.997370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.755500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.639420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.358800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.720300E-02 |
| Normal-VS-Type2 PRCC |
3.628200E-02 |
| Normal-VS-KIRP CIMP |
9.291400E-01 |
| Normal-VS-Unclassified PRCC |
3.168300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.7197999999925E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.514800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.838960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.178200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.842410E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.086800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.211600E-01 |
| Normal-vs-N1 |
3.209200E-01 |
| Normal-vs-N2 |
7.023000E-01 |
| N0-vs-N1 |
2.126600E-01 |
| N0-vs-N2 |
9.595800E-01 |
| N1-vs-N2 |
5.124400E-01 |
|
|
